MiR-126-5p regulates osteolysis formation and stromal cell proliferation in giant cell tumor through inhibition of PTHrP

Bone

Volumn 66, Issue , 2014, Pages 267-276

  Zhou, Wang ^a   Yin, Huabin ^a   Wang, Ting ^a   Liu, Tielong ^a   Li, Zhenxi ^a   Yan, Wangjun ^a   Song, Dianwen ^a   Chen, Haiyan ^b   Chen, Jia ^a   Xu, Wei ^a   Yang, Xinghai ^a   Wu, Zhipeng ^a   Xiao, Jianru ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Giant cell tumor; MiR 126 5p; Osteoclast differentiation; Osteolysis; PTHrP

Indexed keywords

MICRORNA; MICRORNA 126 5P; PARATHYROID HORMONE RELATED PROTEIN; UNCLASSIFIED DRUG; COLLAGENASE 3; INTERLEUKIN 8; MICRORNA 126; MICRORNA 126 5B; OSTEOCLAST DIFFERENTIATION FACTOR; ENDONUCLEASE; MIRN126 MICRORNA, HUMAN;

ANIMAL CELL; ARTICLE; CANCER SURGERY; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOCLASTOMA; OSTEOLYSIS; PROTEIN EXPRESSION; STROMA CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CANCER GENE THERAPY; CELLULAR DISTRIBUTION; CORRELATIONAL STUDY; DOWN REGULATION; DRUG BINDING SITE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; MULTINUCLEAR CELL; PROTEIN RNA BINDING; PTHRP GENE; RNA GENE; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CYCLE CHECKPOINT; COMPLICATION; ETIOLOGY; GENE EXPRESSION PROFILING; GENETIC ENGINEERING; GENETICS; GIANT CELL; GIANT CELL TUMOR; HEK293 CELL LINE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; BONE RESORPTION; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; ENDONUCLEASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ENGINEERING; GIANT CELL TUMORS; GIANT CELLS; HEK293 CELLS; HUMANS; MICE, INBRED C57BL; MICRORNAS; MOLECULAR SEQUENCE DATA; OSTEOLYSIS; PARATHYROID HORMONE-RELATED PROTEIN; STROMAL CELLS;

EID: 84904251162     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.06.021     Document Type: Article

References (39)

1. Gupta R., Seethalakshmi V., Jambhekar N.A., Prabhudesai S., Merchant N., Agarwal M. Clinicopathologic profile of 470 giant cell tumors of bone from a cancer hospital in western India. Ann Diagn Pathol 2008 Aug, 12(4):239-248.
2. Wu Z., Yang X., Xiao J., Feng D., Huang Q., Zheng W., et al. Aneurysmal bone cyst secondary to giant cell tumor of the mobile spine: a report of 11 cases. Spine (Phila Pa 1976) 2011 Oct 1, 36(21):E1385-E1390.
3. Wuelling M., Engels C., Jesse N., Werner M., Kaiser E., Delling G. Histogenesis of giant cell tumors. Pathologe 2002 Sep, 23(5):332-339.
4. Cowan R.W., Ghert M., Singh G. T cells stimulate catabolic gene expression by the stromal cells from giant cell tumor of bone. Biochem Biophys Res Commun 2012 Mar 23, 419(4):719-723.
5. Ghert M., Simunovic N., Cowan R.W., Colterjohn N., Singh G. Properties of the stromal cell in giant cell tumor of bone. Clin Orthop Relat Res 2007 Jun, 459:8-13.
6. Xu W., Li X., Huang W., Wang Y., Han S., Chen S., et al. Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center. Ann Surg Oncol 2013 Mar, 20(3):804-810.
7. Ghert M.A., Rizzo M., Harrelson J.M., Scully S.P. Giant-cell tumor of the appendicular skeleton. Clin Orthop Relat Res 2002 Jul, 400:201-210.
8. Katz E., Nyska M., Okon E., Zajicek G., Robin G. Growth rate analysis of lung metastases from histologically benign giant cell tumor of bone. Cancer 1987 May 15, 59(10):1831-1836.
9. Rock M. Curettage of giant cell tumor of bone. Factors influencing local recurrences and metastasis. Chir Organi Mov. 1990, 75:204-205. [(1 Suppl)].
10. Philbrick W.M., Wysolmerski J.J., Galbraith S., Holt E., Orloff J.J., Yang K.H., et al. Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 1996 Jan, 76(1):127-173.
11. Suva L.J., Winslow G.A., Wettenhall R.E., Hammonds R.G., Moseley J.M., Diefenbach-jagger H., et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987 Aug 21, 237(4817):893-896.
12. Jüppner H., Abou-Samra A.B., Freeman M., Kong X.F., Schipani E., Richards J., et al. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 1991 Nov 15, 254(5034):1024-1026.
13. Mak I.W., Cowan R.W., Turcotte R.E., Singh G., Ghert M. PTHrP induces autocrine/paracrine proliferation of bone tumor cells through inhibition of apoptosis. PLoS One 2011, 6(5):e19975.
14. Mak I.W., Turcotte R.E., Ghert M. Transcriptomic and proteomic analyses in bone tumor cells: deciphering parathyroid hormone-related protein regulation of the cell cycle and apoptosis. J Bone Miner Res 2012 Sep, 27(9):1976-1991.
15. Cowan R.W., Singh G., Ghert M. PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone. J Orthop Res 2012 Jun, 30(6):877-884.
16. Kuo P.L., Liao S.H., Hung J.Y., Huang M.S., Hsu Y.L. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. Biochim Biophys Acta 2013 Jun, 1830(6):3756-3766.
17. Croce C.M., Calin G.A. miRNAs, cancer, and stem cell division. Cell 2005 Jul 15, 122(1):6-7.
18. Fabian M.R., Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 2012 Jun 5, 19(6):586-593.
19. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006 Apr 20, 25(17):2537-2545.
20. Shenouda S.K., Alahari S.K. MicroRNA function in cancer: oncogene or a tumor suppressor?. Cancer Metastasis Rev 2009 Dec, 28(3-4):369-378.
21. Musiyenko A., Bitko V., Barik S. Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells. J Mol Med (Berl) 2008 Mar, 86(3):313-322.
22. Felli N., Felicetti F., Lustri A.M., Errico M.C., Bottero L., Cannistraci A., et al. miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma. PLoS One 2013, 8(2):e56824.
23. Zhang Y., Yang P., Sun T., Li D., Xu X., Rui Y., et al. miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol 2013 Mar, 15(3):284-294.
24. Sanfiorenzo C., Ilie M.I., Belaid A., Barlési F., Mouroux J., Marquette C.H., et al. Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS One 2013, 8(1):e54596.
25. Võsa U., Vooder T., Kolde R., Vilo J., Metspalu A., Annilo T. Meta-analysis of microRNA expression in lung cancer. Int J Cancer 2013 Jun 15, 132(12):2884-2893.
26. Wu X., Li Z., Yang Z., Zheng C., Jing J., Cheng Y., et al. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand-induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+-nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. J Bone Miner Res 2012 Jun, 27(6):1298-1308.
27. Hockemeyer D., Wang H., Kiani S., Lai C.S., Gao Q., Cassady J.P., et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 2011 Jul 7, 29(8):731-734.
28. Furugaki K., Moriya Y., Iwai T., Yorozu K., Yanagisawa M., Kondoh K., et al. Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292. Clin Exp Metastasis 2011 Oct, 28(7):649-659.
29. Hsu Y.L., Hung J.Y., Ko Y.C., Hung C.H., Huang M.S., Kuo P.L. Phospholipase D signaling pathway is involved in lung cancer-derived IL-8 increased osteoclastogenesis. Carcinogenesis 2010 Apr, 31(4):587-596.
30. Pivetta E., Scapolan M., Pecolo M., Wassermann B., Abu-Rumeileh I., Balestreri L., et al. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases. Breast Cancer Res 2011 Oct 27, 13(5):R105.
31. Hess J., Porte D., Munz C., Angel P. AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J Biol Chem 2001 Jun 8, 276(23):20029-20038.
32. Ibaragi S., Shimo T., Iwamoto M., Hassan N.M., Kodama S., Isowa S., et al. Parathyroid hormone-related peptide regulates matrix metalloproteinase-13 gene expression in bone metastatic breast cancer cells. Anticancer Res 2010 Dec, 30(12):5029-5036.
33. Porte D., Tuckermann J., Becker M., Baumann B., Teurich S., Higgins T., et al. Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 1999 Jan 21, 18(3):667-678.
34. Luparello C., Romanotto R., Tipa A., Sirchia R., Olmo N., López de Silanes I., et al. Midregion parathyroid hormone-related protein inhibits growth and invasion in vitro and tumorigenesis in vivo of human breast cancer cells. J Bone Miner Res 2001 Dec, 16(12):2173-2181.
35. Liao J., Mccauley L.K. Skeletal metastasis: established and emerging roles of parathyroid hormone related protein (PTHrP). Cancer Metastasis Rev 2006 Dec, 25(4):559-571.
36. Wu Z., Yin H., Liu T., Yan W., Li Z., Chen J., et al. MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13. Biochem Biophys Res Commun 2014 Jan 17, 443(3):944-949.
37. Downs T.M., Burton D.W., Araiza F.L., Hastings R.H., Deftos L.J. PTHrP stimulates prostate cancer cell growth and upregulates aldo-keto reductase 1C3. Cancer Lett 2011 Jul 1, 306(1):52-59.
38. Bhatia V., Saini M.K., Falzon M. Nuclear PTHrP targeting regulates PTHrP secretion and enhances LoVo cell growth and survival. Regul Pept 2009 Nov 27, 158(1-3):149-155.
39. Bhatia V., Mula R.V., Weigel N.L., Falzon M. Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling. Mol Cancer Res 2009 Jul, 7(7):1119-1131.